31-Mar-17 Without much press or international recognition, Chinese companies have been making good progress enhancing their pharmaceutical and healthcare prowess. For example, in the past few years, 50+ Chinese pharmaceutical companies have entered or completed phase I and phase II clinical trials, while 10+ companies have completed phase III trials. [image: China Money Network

21-Mar-17 Israel's EyeYon Medical has raised USD6.5 mn to develop, test, and seek regulatory approval for its two main solutions: EndoArt, an artificial endothelial layer which can replace the need for cadaver based implants, and Hyper CLTM, a therapeutic soft contact lens. The investment was led by China-based VC Rimonci Capital and Gauss Group, with existing investors Triventures and Pontifax. [image: Globes]

21-Mar-17 Researchers at Sandia National Laboratories in the US have developed a smartphone-controlled, battery-operated, diagnostic device for the detection of Zika, dengue, and chikungunya. The new device eliminates the need for laboratory testing and reduces wait times from several days, to around 30 minutes and would cost in the region of USD100. [image: ET Healthworld]

17-Mar-17 Scientists at the Bhabha Atomic Research Center have developed a micro sized Tele-ECG machine that can transmit an ECG over mobile phones and costs around USD62. The machine can be recharged via a mobile charger and the data can be transmitted via mobile network to a specialist, ideal for use in rural India. [image: NDTV]

17-Mar-17 The Korean company GEOMC and Danish sound specialist company AUDIOWISE have jointly developed a sound therapy solution aimed at reducing symptoms of depression, sleep disturbance, pain, anger, and other similar side effects of prolonged stress. The technology is being tested at Seoul National University’s research centers to provide empirical proof of effectiveness. [image: Business Korea]